Yale University researcher Akiko Iwasaki, Ph.D., says immune profiling shows how Long COVID patients have distinct features not found in control groups. These patients, who also exhibit elevated levels of exhausted T-cells, cause her to express surprise at skeptics.
Iwasaki joins Fiona Lowenstein, editor of “The Long COVID Survival Guide,” to discuss patients who say they’re suffering from Long COVID for as much as two years after their acute phase of the disease.
Iwasaki also explains why her lab’s effort to move forward with a COVID nasal spray faces financial hurdles. Listen in to this important conversation with hosts Mark Masselli and Margaret Flinter.
